Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.aartidrugs.com | |
Market Cap | 4,217.00 Cr. | |
Enterprise Value(EV) | 4,823.52 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 17.96 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 25.36 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 32.05 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 128.77 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 3.54 | Calculated using Price: 455.40 |
Dividend Yield | 0.22 | Period Ending 2022-03 |
No. of Shares Subscribed | 9.26 Cr. | 92,600,000 Shares |
FaceValue | 10 | |
About Aarti Drugs Ltd. | ||
Aarti Drugs (ADL), incorporated in 1984, is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries. |
1 Day |
|
+4.25% |
1 Week |
|
+2.16% |
1 Month |
|
+8.20% |
3 Month |
|
+24.31% |
6 Month |
|
+1.41% |
1 Year |
|
+3.79% |
2 Year |
|
-38.16% |
5 Year |
|
+247.47% |
10 Year |
|
+1598.62% |
9 years | 2011-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 15.18 | 32.78 | 20.65 | 21.60 | 19.24 | 17.97 | 23.65 | 35.81 | 21.03 | |
Return on Capital Employed (%) | 13.12 | 23.93 | 17.95 | 18.14 | 17.31 | 17.01 | 21.39 | 34.52 | 20.75 | |
Return on Assets (%) | 4.99 | 10.13 | 6.53 | 7.13 | 6.38 | 6.31 | 9.33 | 16.78 | 10.32 |
Particulars | 10 years | 2011-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 163 | 308 | 357 | 400 | 455 | 543 | 652 | 913 | 1,036 | 1,192 | |
Non Curr. Liab. | 290 | 211 | 244 | 297 | 312 | 321 | 301 | 257 | 232 | 296 | |
Curr. Liab. | 70 | 483 | 501 | 494 | 622 | 591 | 623 | 595 | 940 | 933 | |
Minority Int. | 0 | 0 | 0 | ||||||||
Equity & Liab. | 523 | 1,002 | 1,102 | 1,191 | 1,389 | 1,455 | 1,577 | 1,766 | 2,208 | 2,421 | |
Non Curr. Assets | 264 | 476 | 537 | 620 | 653 | 671 | 673 | 709 | 815 | 929 | |
Curr. Assets | 260 | 526 | 565 | 571 | 737 | 784 | 904 | 1,057 | 1,393 | 1,492 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 523 | 1,002 | 1,102 | 1,191 | 1,389 | 1,455 | 1,577 | 1,766 | 2,208 | 2,421 |
Particulars | 10 years | 2011-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 501 | 1,097 | 1,140 | 1,195 | 1,244 | 1,561 | 1,806 | 2,155 | 2,489 | 2,716 | |
Other Income | 0 | 1 | 4 | 1 | 2 | 1 | 5 | 11 | 2 | ||
Total Income | 501 | 1,098 | 1,140 | 1,199 | 1,245 | 1,563 | 1,808 | 2,159 | 2,500 | 2,718 | |
Total Expenditure | -432 | -925 | -960 | -1,005 | -1,042 | -1,350 | -1,541 | -1,714 | -2,156 | -2,410 | |
PBIDT | 69 | 173 | 180 | 194 | 203 | 213 | 267 | 445 | 344 | 308 | |
Interest | -17 | -42 | -48 | -40 | -38 | -44 | -37 | -26 | -24 | -33 | |
Depreciation | -19 | -31 | -37 | -38 | -40 | -43 | -49 | -50 | -50 | -50 | |
Taxation | -10 | -22 | -27 | -34 | -42 | -41 | -44 | -89 | -65 | -58 | |
Exceptional Items | 4 | 4 | 0 | ||||||||
PAT | 24 | 77 | 69 | 82 | 82 | 90 | 141 | 280 | 205 | 166 | |
Minority Interest | 0 | 0 | 0 | ||||||||
Share Associate | 0 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 24 | 77 | 69 | 82 | 82 | 90 | 141 | 280 | 205 | 166 | |
Adjusted EPS | 2 | 8 | 7 | 9 | 9 | 10 | 15 | 30 | 22 | 18 |
Particulars | 10 years | 2010-03 Rs. Cr. | 2011-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 59 | 21 | 105 | 133 | 175 | 70 | 143 | 251 | 155 | 70 | |
Cash Fr. Inv. | -30 | -76 | -107 | -99 | -107 | -74 | -62 | -33 | -72 | -149 | |
Cash Fr. Finan. | -24 | 53 | 1 | -33 | -68 | 4 | -80 | -215 | -81 | 92 | |
Net Change | 5 | -3 | -1 | 1 | 0 | 0 | 1 | 2 | 2 | 13 | |
Cash & Cash Eqvt | 9 | 5 | 4 | 5 | 3 | 3 | 5 | 7 | 9 | 22 |
Fri, 26 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Annual Secretarial Compliance Report for the FY ended March 31 2023. |
Mon, 22 May 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of Loss of Share Certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Wed, 17 May 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for issuance of Letter of Confirmation in lieu of Duplicate Share Certificate |
Thu, 01 Jun 2023 |
|
|
|
|
|